Literature DB >> 25234815

Coronary endothelial dysfunction is associated with inflammation and vasa vasorum proliferation in patients with early atherosclerosis.

Byoung-Joo Choi1, Yoshiki Matsuo1, Tatsuo Aoki1, Taek-Geun Kwon1, Abhiram Prasad1, Rajiv Gulati1, Ryan J Lennon1, Lilach O Lerman1, Amir Lerman2.   

Abstract

OBJECTIVE: Endothelial dysfunction is an early manifestation of atherosclerosis. Inflammation and vasa vasorum play a pivotal role in the pathophysiology of plaque initiation, development, and complications. Optical coherence tomography allows high-resolution imaging of tissue microstructure. Therefore, the aim of this study was to test the hypothesis that segments with endothelial dysfunction show macrophages and vasa vasorum in patients with early coronary artery disease. APPROACH AND
RESULTS: Optical coherence tomography images were obtained from 40 patients with mild coronary atherosclerosis who underwent coronary endothelial function assessment. Optical coherence tomography findings, including macrophages and microchannels, were evaluated in 76 coronary segments corresponding to those in endothelial response to acetylcholine. Coronary artery diameter change in response to acetylcholine was more severe in segments showing macrophages (-17.7±14.7% versus -6.3±13.9%; P<0.01) and microchannels (-15.9±15.9% versus -6.4±13.5%; P<0.01) than those without. There were increasing trends of the prevalence of macrophages and microchannels with endothelial dysfunction as stratified by quartiles of coronary artery diameter change (P<0.01 and P=0.02 for trend, respectively). In particular, segments with both macrophages and microchannels (n=12) tended to have worse endothelial function than those with macrophages alone (n=15) and microchannels alone (n=15; -22.1±14.6% versus -10.9±15.6% and -10.9±15.6%; P=0.07 and P=0.06, respectively).
CONCLUSIONS: Epicardial endothelial dysfunction was associated with optical coherence tomography -identified macrophages and microchannels in mild coronary atherosclerosis. The current study further supports the role of inflammation and vasa vasorum proliferation in the early stage of coronary atherosclerosis.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  coronary disease; inflammation; optical coherence tomography

Mesh:

Substances:

Year:  2014        PMID: 25234815      PMCID: PMC4212523          DOI: 10.1161/ATVBAHA.114.304445

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  33 in total

Review 1.  The clinical implications of endothelial dysfunction.

Authors:  Michael E Widlansky; Noyan Gokce; John F Keaney; Joseph A Vita
Journal:  J Am Coll Cardiol       Date:  2003-10-01       Impact factor: 24.094

2.  Thin-cap fibroatheroma and microchannel findings in optical coherence tomography correlate with subsequent progression of coronary atheromatous plaques.

Authors:  Shiro Uemura; Ken-ichi Ishigami; Tsunenari Soeda; Satoshi Okayama; Ji Hee Sung; Hitoshi Nakagawa; Satoshi Somekawa; Yukiji Takeda; Hiroyuki Kawata; Manabu Horii; Yoshihiko Saito
Journal:  Eur Heart J       Date:  2011-08-10       Impact factor: 29.983

Review 3.  Endothelial function and dysfunction: testing and clinical relevance.

Authors:  John E Deanfield; Julian P Halcox; Ton J Rabelink
Journal:  Circulation       Date:  2007-03-13       Impact factor: 29.690

4.  Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering.

Authors:  Stephanie H Wilson; Joerg Herrmann; Lilach O Lerman; David R Holmes; Claudio Napoli; Erik L Ritman; Amir Lerman
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

5.  Fatty streak assessed by optical coherence tomography: early atherosclerosis detection.

Authors:  Manabu Kashiwagi; Hironori Kitabata; Yuichi Ozaki; Toshio Imanishi; Takashi Akasaka
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2012-08-28       Impact factor: 6.875

Review 6.  Systemic nature of endothelial dysfunction in atherosclerosis.

Authors:  T J Anderson; M D Gerhard; I T Meredith; F Charbonneau; D Delagrange; M A Creager; A P Selwyn; P Ganz
Journal:  Am J Cardiol       Date:  1995-02-23       Impact factor: 2.778

7.  Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia.

Authors:  J Herrmann; L O Lerman; M Rodriguez-Porcel; D R Holmes; D M Richardson; E L Ritman; A Lerman
Journal:  Cardiovasc Res       Date:  2001-09       Impact factor: 10.787

8.  Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography.

Authors:  Guillermo J Tearney; Hiroshi Yabushita; Stuart L Houser; H Thomas Aretz; Ik-Kyung Jang; Kelly H Schlendorf; Christopher R Kauffman; Milen Shishkov; Elkan F Halpern; Brett E Bouma
Journal:  Circulation       Date:  2003-01-07       Impact factor: 29.690

9.  Atherosclerosis in the back yard.

Authors:  Joerg Herrmann; Amir Lerman
Journal:  J Am Coll Cardiol       Date:  2007-05-17       Impact factor: 24.094

10.  Coronary endothelial dysfunction in patients with early coronary artery disease is associated with the increase in intravascular lipid core plaque.

Authors:  Byoung-Joo Choi; Abhiram Prasad; Rajiv Gulati; Patricia J Best; Ryan J Lennon; Gregory W Barsness; Lilach O Lerman; Amir Lerman
Journal:  Eur Heart J       Date:  2013-04-07       Impact factor: 29.983

View more
  24 in total

Review 1.  Regulation of Coronary Blood Flow.

Authors:  Adam G Goodwill; Gregory M Dick; Alexander M Kiel; Johnathan D Tune
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

2.  Long-term darapladib use does not affect coronary plaque composition assessed using multimodality intravascular imaging modalities: a randomized-controlled study.

Authors:  Woong Gil Choi; Megha Prasad; Ryan Lennon; Rajiv Gulati; Abhiram Prasad; Lilach O Lerman; Amir Lerman
Journal:  Coron Artery Dis       Date:  2018-03       Impact factor: 1.439

3.  Loss of Reelin protects against atherosclerosis by reducing leukocyte-endothelial cell adhesion and lesion macrophage accumulation.

Authors:  Yinyuan Ding; Linzhang Huang; Xunde Xian; Ivan S Yuhanna; Catherine R Wasser; Michael Frotscher; Chieko Mineo; Philip W Shaul; Joachim Herz
Journal:  Sci Signal       Date:  2016-03-15       Impact factor: 8.192

Review 4.  Imaging inflammation and neovascularization in atherosclerosis: clinical and translational molecular and structural imaging targets.

Authors:  Eric A Osborn; Farouc A Jaffer
Journal:  Curr Opin Cardiol       Date:  2015-11       Impact factor: 2.161

Review 5.  Viewpoint: Recent Advances in Intracoronary Imaging for Vasa Vasorum Visualisation.

Authors:  Kensuke Nishimiya; Yasuharu Matsumoto; Hiroaki Shimokawa
Journal:  Eur Cardiol       Date:  2017-12

6.  Long Noncoding RNA HOXA-AS3 Integrates NF-κB Signaling To Regulate Endothelium Inflammation.

Authors:  Xinxing Zhu; Duchu Chen; Yanli Liu; Jinjin Yu; Liang Qiao; Shuibin Lin; Demeng Chen; Genshen Zhong; Xifeng Lu; Yize Wang; Jieqi Wen; Xinqi Zhong; Yizhou Jiang
Journal:  Mol Cell Biol       Date:  2019-09-11       Impact factor: 4.272

Review 7.  Atherosclerosis.

Authors:  Hong Lu; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-03       Impact factor: 8.311

8.  Coronary Artery Remodeling and Fibrosis With Continuous-Flow Left Ventricular Assist Device Support.

Authors:  Amrut V Ambardekar; Mary C M Weiser-Evans; Marcella Li; Suneet N Purohit; Muhammad Aftab; T Brett Reece; Karen S Moulton
Journal:  Circ Heart Fail       Date:  2018-05       Impact factor: 8.790

Review 9.  Systems Biology and Noninvasive Imaging of Atherosclerosis.

Authors:  Claudia Calcagno; Willem J M Mulder; Matthias Nahrendorf; Zahi A Fayad
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-02       Impact factor: 8.311

Review 10.  Mechanisms and clinical implications of endothelium-dependent vasomotor dysfunction in coronary microvasculature.

Authors:  Sharif A Sabe; Jun Feng; Frank W Sellke; M Ruhul Abid
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-03-25       Impact factor: 5.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.